全文获取类型
收费全文 | 8328篇 |
免费 | 795篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 230篇 |
妇产科学 | 158篇 |
基础医学 | 1080篇 |
口腔科学 | 118篇 |
临床医学 | 927篇 |
内科学 | 1657篇 |
皮肤病学 | 90篇 |
神经病学 | 661篇 |
特种医学 | 286篇 |
外科学 | 1606篇 |
综合类 | 204篇 |
一般理论 | 26篇 |
预防医学 | 853篇 |
眼科学 | 72篇 |
药学 | 556篇 |
中国医学 | 51篇 |
肿瘤学 | 506篇 |
出版年
2023年 | 55篇 |
2022年 | 60篇 |
2021年 | 125篇 |
2020年 | 119篇 |
2019年 | 172篇 |
2018年 | 198篇 |
2017年 | 147篇 |
2016年 | 161篇 |
2015年 | 152篇 |
2014年 | 233篇 |
2013年 | 344篇 |
2012年 | 527篇 |
2011年 | 506篇 |
2010年 | 272篇 |
2009年 | 260篇 |
2008年 | 483篇 |
2007年 | 439篇 |
2006年 | 398篇 |
2005年 | 436篇 |
2004年 | 387篇 |
2003年 | 331篇 |
2002年 | 318篇 |
2001年 | 236篇 |
2000年 | 256篇 |
1999年 | 202篇 |
1998年 | 86篇 |
1997年 | 77篇 |
1996年 | 92篇 |
1995年 | 69篇 |
1994年 | 81篇 |
1993年 | 70篇 |
1992年 | 124篇 |
1991年 | 153篇 |
1990年 | 104篇 |
1989年 | 103篇 |
1988年 | 122篇 |
1987年 | 145篇 |
1986年 | 124篇 |
1985年 | 107篇 |
1984年 | 68篇 |
1983年 | 59篇 |
1982年 | 42篇 |
1980年 | 47篇 |
1979年 | 68篇 |
1978年 | 46篇 |
1977年 | 55篇 |
1976年 | 38篇 |
1975年 | 41篇 |
1974年 | 49篇 |
1972年 | 42篇 |
排序方式: 共有9132条查询结果,搜索用时 0 毫秒
81.
82.
83.
Continuing hepatitis B virus (HBV) infection is normally associated with the presence of hepatitis B surface antigen (HBsAg) in the serum. In spite of sensitive screening assays for HBsAg, rare cases of post-transfusion HBV infection are still observed. Antibody to hepatitis B core antigen (anti-HBc) often indicates remote HBV infection but DNA hybridisation and more sensitive polymerase chain reaction (PCR) assays have demonstrated that some HBsAg negative individuals, positive for anti-HBc, have continuing HBV replication. To determine the incidence of ongoing HBV infection in a Canadian HBsAg negative, anti-HBc positive population we studied three groups with this combination of HBV markers: Group A, 36 patients referred for investigation of raised serum aminotransferases; Group B, 21 Canadian Red Cross blood donors; Group C, seven vaccinees in an Ottawa Health Care Student hepatitis B vaccination programme. The PCR was carried out using a nested PCR reaction with primers specific for the pre-core region of HBV. Seven of 36 (19%) patients in Group A had detectable HBV DNA whereas none of Group B or C were positive. This data indicates that in some HBsAg negative patients with ongoing hepatic inflammation, continuing HBV replication may persist. This was not observed in any healthy blood donors or health care students investigated. Larger studies are required, but this data would suggest that, in Canada, the addition of anti-HBc testing for all blood donors for detection of low level HBV replication would not be indicated. © 1994 Wiley-Liss, Inc. 相似文献
84.
Malignancies in the acquired immunodeficiency syndrome 总被引:1,自引:0,他引:1
Alexandra M. Levine M.D. Parkash S. Gill M.D. Franco Muggia M.D. 《Current problems in cancer》1987,11(4):209-255
Aside from opportunistic infections, several neoplasms have been identified as part of the spectrum of acquired immunodeficiency syndrome (AIDS) as defined by the Centers for Disease Control. Kaposi's sarcoma (KS) was the first such neoplasm to be recognized within the spectrum of AIDS. Although the classic form of Kaposi's sarcoma had been well recognized prior to the epidemic of AIDS, it was quite distinct from the illness that was seen in its "epidemic" form in young homosexual males. In this setting, Kaposi's sarcoma is an aggressive disease, with extensive involvement of skin and mucous membranes, early dissemination to lymph nodes, impressive development of extreme lymphedema, even in the absence of bulky adenopathy, and rapid spread to visceral organs, including lungs and gastrointestinal tract, among others. Although rapid clinical progression and short median survival have been the rule, a spectrum of disease has been seen such that some patients have survived for many years with disease limited to the skin. Certain clinical and laboratory features, such as presence of unexplained fever, night sweats, weight loss ("B" symptoms), or significant T-4-lymphocytopenia, have been identified as indicators of poor prognosis. Various therapeutic interventions have been employed in epidemic KS, and although partial and complete remissions have occurred, no regimen yet reported has significantly improved the survival of treated patients. High-dose recombinant alpha interferon has produced response rates in approximately 30% of treated patients, although toxicity has been observed in approximately 30% as well. Likewise, vinblastine has produced similar response rates with no evidence of long-term efficacy or "cure." Aside from Kaposi's sarcoma, lymphoma primary to the central nervous system was recognized early in the AIDS epidemic as a criterion for inclusion within AIDS in patients less than sixty years of age. Several years after the initial reports of disease, it became apparent that specific types of systemic lymphoma were also quite extraordinary, and the definition of AIDS was amended in June 1985 to include high-grade B-cell lymphomas in individuals who had positive serology or virology for the human immunodeficiency virus (HIV). The AIDS-related lymphomas are characteristic, both pathologically and clinically. The vast majority of these cases have been high-grade B-lymphoid tumors of either immunoblastic or small-non-cleaved type (also known as "undifferentiated," Burkitt, or Burkitt-like).(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
85.
In a double-blind, crossover comparison, 236 patients with metastatic prostate cancer were randomized to receive estramustine phosphate (EMP) or diethylstilbestrol (DES). Previously castrated patients (66) were separately randomized. Patients kept taking their first drug until progression was proved by objective studies, at which time alternative treatment was begun. The primary determinant of efficacy was the duration between start of therapy and date of objective progression. Uncastrated patients treated with EMP had a significantly longer duration without progression than those treated with DES (p less than 0.01). The following subcategories of entry were further evaluated: little or no pain, moderate to severe pain, little reduction in activity, significant reduction in activity, presence or absence of cardiovascular disease, age above or below 70 years, and "good" or "bad" histology. For all but the last category, EMP was statistically superior to DES. Patients who underwent orchiectomy less than 3 months before randomization had nonprogression rates similar to those for noncastrated men in both groups. Secondary (crossover) therapy was less effective than first therapy in both groups: 46% of patients receiving EMP and 40% receiving DES had no progression at 6 months. Clinical and laboratory adverse experiences were similar for both drugs, except that gastrointestinal disturbances were more common in the EMP group. 相似文献
86.
Summary Floating knee is the term used to describe simultaneous fractures of the femur and tibia in the same limb. Thirty nine patients, with 40 such injuries, are presented with a follow up interval of six months to five years. The final functional result was poor if the femoral fracture was situated in the condylar flare and the results were comparatively better in those cases treated by cast bracing or when the fracture of the femur was stabilised internally. In all cases the fracture of the tibia was treated conservatively.
Résumé Sous le terme de «genou flottant» les auteurs décrivent les fractures simultanées du fémur et du tibia au niveau du même membre. Ils présentent 40 lésions de ce type, chez 39 sujets, avec un recul compris entre six mois et cinq ans. Le résultat fonctionnel est médiocre lorsque le siège de la fracture du fémur est juxta-articulaire. Comparativement, les résultats sont meilleurs lorsque la fracture du fémur a été immobilisée dans une attelle plâtrée ou stabilisée par ostéosynthèse. Toutes les fractures du tibia ont été traitées orthopédiquement.相似文献
87.
Goodman William Downing Amy Allsop Matthew Munro Julie Taylor Claire Hubbard Gill Beeken Rebecca J. 《Quality of life research》2022,31(8):2435-2444
Quality of Life Research - Quality of life can be negatively impacted by the formation of a stoma and is influenced by a number of factors. Research to date treats people with a stoma as a... 相似文献
88.
Mauricio Anne M. Rudo-Stern Jenna Dishion Thomas J. Shaw Daniel S. Gill Anne M. Lundgren Julie S. Thunberg Jenny 《Prevention science》2021,22(1):73-83
Prevention Science - This study is a qualitative analysis of facilitators and barriers in the dissemination of Family Check-Up (FCU), a U.S.-developed preventive intervention in Sweden. The FCU is... 相似文献
89.
Christine M. Lin Ronald G. Gill Borna Mehrad 《American journal of transplantation》2021,21(11):3550-3560
Chronic rejection is among the most pressing clinical challenges in solid organ transplantation. Interestingly, in a mouse model of heterotopic heart transplantation, antibody-dependent, natural killer (NK) cell-mediated chronic cardiac allograft vasculopathy occurs in some donor–recipient strain combinations, but not others. In this study, we sought to identify the mechanism underlying this unexplained phenomenon. Cardiac allografts from major histocompatibility complex (MHC) mismatched donors were transplanted into immune-deficient C57Bl/6.rag−/− recipients, followed by administration of a monoclonal antibody against the donor MHC class I antigen. We found marked allograft vasculopathy in hearts from C3H donors, but near-complete protection of BALB/c allografts from injury. We found no difference in recipient NK cell phenotype or intrinsic responsiveness to activating signals between recipients of C3H versus BALB/c allografts. However, cardiac endothelial cells from C3H allografts showed an approximately twofold higher expression of Rae-1, an activating ligand of the NK cell receptor natural killer group 2D (NKG2D). Importantly, the administration of a neutralizing antibody against NKG2D abrogated the development of allograft vasculopathy in recipients of C3H allografts, even in the presence of donor-specific antibodies. Therefore, the activating NK cell receptor NKG2D is necessary in this model of chronic cardiac allograft vasculopathy, and strain-dependent expression of NK activating ligands correlates with the development of this disease. 相似文献
90.
The aim of the present paper was to identify, appraise, and synthesize the available evidence on two‐stage revision hip arthroplasty with or without the use of an interim spacer for managing late prosthetic infection. The review methodology was designed by referencing the Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) checklist and flow diagram, and a Population, Intervention, Comparator, Outcomes and Study (PICOS) design framework was used to search for studies to incorporate within the review. Two independent investigators were involved in searching for relevant articles that fulfilled the inclusion criteria for the study. Critical appraisal of the selected articles was carried out using the relevant Critical Appraisal Skills Programme checklists. From an initial pool of 125 articles, four studies satisfied the inclusion criteria and quality assessment and were included for final review. Two patient groups were identified from within the selected studies: spacer and non‐spacer. Both groups were assessed in terms of functional outcome, infection cure rates, and technical difficulties encountered during treatment. Better functional outcome was reported in the spacer group, both in the interim period between the two stages and after completion of treatment. The use of spacers reduced operative difficulty during the second stage and accelerated patient discharge. Reinfection and infection persistence rates were higher in the non‐spacer group. Within the spacer group, articulated spacers performed better in all parameters. The results of this review reinforce the available evidence supporting the use of interim hip spacers in revision hip arthroplasty for managing prosthetic infection and also indicate that articulated hip spacers could be an attractive option going forward. 相似文献